245 related articles for article (PubMed ID: 19092668)
21. Tissue engineering of heart valves in vivo using bone marrow-derived cells.
Kim SS; Lim SH; Hong YS; Cho SW; Ryu JH; Chang BC; Choi CY; Kim BS
Artif Organs; 2006 Jul; 30(7):554-7. PubMed ID: 16836737
[TBL] [Abstract][Full Text] [Related]
22. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering.
Aikawa E; Whittaker P; Farber M; Mendelson K; Padera RF; Aikawa M; Schoen FJ
Circulation; 2006 Mar; 113(10):1344-52. PubMed ID: 16534030
[TBL] [Abstract][Full Text] [Related]
23. Force generation of different human cardiac valve interstitial cells: relevance to individual valve function and tissue engineering.
Smith S; Taylor PM; Chester AH; Allen SP; Dreger SA; Eastwood M; Yacoub MH
J Heart Valve Dis; 2007 Jul; 16(4):440-6. PubMed ID: 17702371
[TBL] [Abstract][Full Text] [Related]
24. Cultured interstitial cells from human heart valves express both specific skeletal muscle and non-muscle markers.
Brand NJ; Roy A; Hoare G; Chester A; Yacoub MH
Int J Biochem Cell Biol; 2006 Jan; 38(1):30-42. PubMed ID: 16154797
[TBL] [Abstract][Full Text] [Related]
25. Cholesterol-modified polyurethane valve cusps demonstrate blood outgrowth endothelial cell adhesion post-seeding in vitro and in vivo.
Stachelek SJ; Alferiev I; Connolly JM; Sacks M; Hebbel RP; Bianco R; Levy RJ
Ann Thorac Surg; 2006 Jan; 81(1):47-55. PubMed ID: 16368333
[TBL] [Abstract][Full Text] [Related]
26. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves.
Rabkin-Aikawa E; Farber M; Aikawa M; Schoen FJ
J Heart Valve Dis; 2004 Sep; 13(5):841-7. PubMed ID: 15473488
[TBL] [Abstract][Full Text] [Related]
27. In vivo tissue engineering of heart valves: evolution of a novel concept.
Schleicher M; Wendel HP; Fritze O; Stock UA
Regen Med; 2009 Jul; 4(4):613-9. PubMed ID: 19580409
[TBL] [Abstract][Full Text] [Related]
28. Tissue engineering of heart valves by recellularization of glutaraldehyde-fixed porcine valves using bone marrow-derived cells.
Kim SS; Lim SH; Cho SW; Gwak SJ; Hong YS; Chang BC; Park MH; Song KW; Choi CY; Kim BS
Exp Mol Med; 2006 Jun; 38(3):273-83. PubMed ID: 16819286
[TBL] [Abstract][Full Text] [Related]
29. Flow-dependent re-endothelialization of tissue-engineered heart valves.
Lichtenberg A; Cebotari S; Tudorache I; Sturz G; Winterhalter M; Hilfiker A; Haverich A
J Heart Valve Dis; 2006 Mar; 15(2):287-93; discussion 293-4. PubMed ID: 16607913
[TBL] [Abstract][Full Text] [Related]
30. In-vitro seeding of human umbilical cord vein endothelial cells on hydroxyapatite for mechanical heart valve applications.
Sha JM; Yan ZY; Cheng GC; Weil XY; Tao YQ; Li YM; Luo L
J Heart Valve Dis; 2010 Jul; 19(4):506-12. PubMed ID: 20845900
[TBL] [Abstract][Full Text] [Related]
31. Bioengineered self-seeding heart valves.
Jordan JE; Williams JK; Lee SJ; Raghavan D; Atala A; Yoo JJ
J Thorac Cardiovasc Surg; 2012 Jan; 143(1):201-8. PubMed ID: 22047685
[TBL] [Abstract][Full Text] [Related]
32. [Preparation of heart valve scaffold and cell seeding].
Long L; Wu C; Pan L; Qi X; Hong T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Aug; 21(4):610-3. PubMed ID: 15357443
[TBL] [Abstract][Full Text] [Related]
33. Autologous human tissue-engineered heart valves: prospects for systemic application.
Mol A; Rutten MC; Driessen NJ; Bouten CV; Zünd G; Baaijens FP; Hoerstrup SP
Circulation; 2006 Jul; 114(1 Suppl):I152-8. PubMed ID: 16820565
[TBL] [Abstract][Full Text] [Related]
34. Lack of ABH-antigen expression on human cardiac valves.
Kadner A; Chen RH; Mitchell RN; Adams DH
J Heart Valve Dis; 2000 Jul; 9(4):512-6. PubMed ID: 10947043
[TBL] [Abstract][Full Text] [Related]
35. Tissue factor and thrombomodulin expression on endothelial cell-seeded collagen modules for tissue engineering.
She M; McGuigan AP; Sefton MV
J Biomed Mater Res A; 2007 Feb; 80(2):497-504. PubMed ID: 17111414
[TBL] [Abstract][Full Text] [Related]
36. Tissue engineering of heart valves: advances and current challenges.
Mol A; Smits AI; Bouten CV; Baaijens FP
Expert Rev Med Devices; 2009 May; 6(3):259-75. PubMed ID: 19419284
[TBL] [Abstract][Full Text] [Related]
37. In vitro endothelialization of bioprosthetic heart valves provides a cell monolayer with proliferative capacities and resistance to pulsatile flow.
Jansson K; Bengtsson L; Swedenborg J; Haegerstrand A
J Thorac Cardiovasc Surg; 2001 Jan; 121(1):108-15. PubMed ID: 11135167
[TBL] [Abstract][Full Text] [Related]
38. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model.
Flanagan TC; Sachweh JS; Frese J; Schnöring H; Gronloh N; Koch S; Tolba RH; Schmitz-Rode T; Jockenhoevel S
Tissue Eng Part A; 2009 Oct; 15(10):2965-76. PubMed ID: 19320544
[TBL] [Abstract][Full Text] [Related]
39. Preclinical development of tissue-engineered vein valves and venous substitutes using re-endothelialised human vein matrix.
Teebken OE; Puschmann C; Breitenbach I; Rohde B; Burgwitz K; Haverich A
Eur J Vasc Endovasc Surg; 2009 Jan; 37(1):92-102. PubMed ID: 19008126
[TBL] [Abstract][Full Text] [Related]
40. Human vascular smooth muscle cells and endothelial cells cocultured on polyglycolic acid (70/30) scaffold in tissue engineered vascular graft.
Wen SJ; Zhao LM; Wang SG; Li JX; Chen HY; Liu JL; Liu Y; Luo Y; Changizi R
Chin Med J (Engl); 2007 Aug; 120(15):1331-5. PubMed ID: 17711739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
